SITC Workshop on Immunotherapy Combinations
November 3, 2011
Bethesda North Marriott Hotel & Conference Center
North Bethesda, MD
This one day Workshop on Immunotherapy Combinations included presentations by leaders in the field as well as panel discussions on strategies combining various cancer immunotherapies and conventional cancer treatments. Logistical issues in immunotherapy combination trials were presented, including from the regulatory, legal, and industry perspectives, and from the perspective of independent academic investigators. Current clinical trial efforts on immunotherapy combinations were discussed, emphasizing considerations and applications for future trials.
Topics Addressed:
- Immunotherapy Combination with Other Immunotherapies
- Immunotherapy Combinations with Conventional Cancer Therapies
- Logistical Issues: Regulatory, Legal, Industry and Academic Perspectives
- Clinical Trial Efforts – What Have We Learned?
Organizers
Alan J. Korman, PhD – Bristol-Myers Squibb
Ignacio Melero, MD, PhD – University of Navarra
Hideho Okada, MD, PhD – University of Pittsburgh Cancer Institute
Suzanne L. Topalian, MD – Johns Hopkins University School of Medicine
